🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/09/2023 | 107,54 | 109,14 | 107,54 | 109,05 | +1,03% | 1,49% | 6.807.500 |
| 07/09/2023 | 106,91 | 108,69 | 106,86 | 107,94 | +1,36% | 1,71% | 8.532.600 |
| 06/09/2023 | 106,76 | 107,00 | 104,92 | 106,49 | -0,95% | 1,95% | 7.926.100 |
| 05/09/2023 | 109,46 | 109,72 | 107,49 | 107,51 | -2,12% | 2,04% | 6.379.900 |
| 01/09/2023 | 109,65 | 110,37 | 109,25 | 109,84 | +0,79% | 1,02% | 4.941.300 |
| 31/08/2023 | 110,12 | 110,54 | 108,89 | 108,98 | -1,12% | 1,50% | 9.212.000 |
| 30/08/2023 | 110,30 | 110,80 | 109,72 | 110,21 | +0,20% | 0,98% | 4.785.000 |
| 29/08/2023 | 109,28 | 110,52 | 108,93 | 109,99 | +0,97% | 1,45% | 5.673.100 |
| 28/08/2023 | 110,23 | 110,61 | 108,65 | 108,93 | -1,16% | 1,78% | 4.335.600 |
| 25/08/2023 | 109,94 | 110,33 | 108,98 | 110,21 | +0,69% | 1,23% | 4.839.100 |
| 24/08/2023 | 110,95 | 112,02 | 109,09 | 109,45 | -1,66% | 2,64% | 6.487.700 |
| 23/08/2023 | 109,99 | 111,89 | 109,82 | 111,30 | +3,80% | 1,88% | 10.588.200 |
| 22/08/2023 | 109,60 | 109,60 | 107,20 | 107,23 | -2,20% | 2,19% | 6.026.000 |
| 21/08/2023 | 109,09 | 110,00 | 108,95 | 109,64 | +0,40% | 0,96% | 6.012.500 |
| 18/08/2023 | 108,97 | 109,50 | 108,21 | 109,20 | +0,26% | 1,18% | 6.711.400 |
| 17/08/2023 | 108,66 | 110,28 | 108,32 | 108,92 | +0,17% | 1,80% | 6.457.800 |
| 16/08/2023 | 108,50 | 109,47 | 108,28 | 108,73 | +0,06% | 1,10% | 5.332.900 |
| 15/08/2023 | 108,89 | 109,42 | 108,42 | 108,66 | -0,23% | 0,92% | 5.118.700 |
| 14/08/2023 | 107,92 | 109,43 | 107,31 | 108,91 | +1,37% | 1,96% | 8.427.200 |
| 11/08/2023 | 105,95 | 107,71 | 105,59 | 107,44 | +1,77% | 2,00% | 5.904.300 |
| 10/08/2023 | 106,21 | 107,04 | 105,42 | 105,57 | -0,50% | 1,53% | 6.525.700 |
| 09/08/2023 | 106,27 | 106,79 | 105,79 | 106,10 | -0,29% | 0,94% | 6.479.500 |
| 08/08/2023 | 105,69 | 107,19 | 105,69 | 106,41 | +0,30% | 1,42% | 10.152.200 |
| 07/08/2023 | 105,29 | 106,28 | 104,42 | 106,09 | +1,04% | 1,77% | 8.259.100 |
| 04/08/2023 | 105,64 | 106,42 | 104,51 | 105,00 | -0,69% | 1,81% | 6.700.700 |
| 03/08/2023 | 105,08 | 105,78 | 104,87 | 105,73 | +0,03% | 0,87% | 6.039.300 |
| 02/08/2023 | 106,03 | 108,14 | 104,88 | 105,70 | +0,40% | 3,07% | 10.873.500 |
| 01/08/2023 | 109,60 | 109,60 | 105,14 | 105,28 | -1,28% | 4,07% | 10.009.200 |
| 31/07/2023 | 106,55 | 106,77 | 105,67 | 106,65 | +0,29% | 1,03% | 7.397.500 |
| 28/07/2023 | 105,43 | 106,65 | 105,24 | 106,34 | +1,02% | 1,34% | 6.903.800 |